Patients with TP53 -Mutated Acute Myeloid Leukemia Receiving Intensive Induction Therapy Have Superior Outcomes Due to a Higher Rate of Salvage Therapy: A Single Institution, Retrospective Study.
Nuttavut SumransubGabriel K SteinwandKeith CordnerYoonkyu LeeQing CaoJeremy AllredVeronika BachanovaMark JuckettCraig E EckfeldtJoseph E MaakaronSean I TracyVidhyalakshmi RameshAndrew Cook NelsonSophia L YoheZohar SachsPublished in: Cancers (2024)
m AML patients.
Keyphrases
- acute myeloid leukemia
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- allogeneic hematopoietic stem cell transplantation
- peritoneal dialysis
- prognostic factors
- type diabetes
- stem cells
- mesenchymal stem cells
- adipose tissue
- metabolic syndrome
- bone marrow
- skeletal muscle
- insulin resistance
- patient reported
- weight loss
- replacement therapy